Dietary Supplement
Branched Chain Amino Acid
Branched Chain Amino Acid is a dietary supplement with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_1
1
20%
Ph not_applicable
3
60%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Other(1)
Detailed Status
Completed3
Active, not recruiting1
Suspended1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 31 (20.0%)
N/A3 (60.0%)
Trials by Status
completed360%
active_not_recruiting120%
suspended120%
Recent Activity
1 active trials
Showing 5 of 5
active_not_recruitingphase_3
Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
NCT03633279
completednot_applicable
Effect of BCAA Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in CLD Patients
NCT04246918
completedphase_1
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
NCT04238416
completednot_applicable
Nutritional Intervention for Sarcopenia
NCT03891134
suspendednot_applicable
Exercise and Branched Chain Amino Acids (BCAA)Requirements in Older Men
NCT01931722
Clinical Trials (5)
Showing 5 of 5 trials
NCT03633279Phase 3
Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
NCT04246918Not Applicable
Effect of BCAA Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in CLD Patients
NCT04238416Phase 1
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
NCT03891134Not Applicable
Nutritional Intervention for Sarcopenia
NCT01931722Not Applicable
Exercise and Branched Chain Amino Acids (BCAA)Requirements in Older Men
All 5 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 5